#1 Clinical Trials Search in Europe

Formoterol Fumarate

This article examines the use of Formoterol Fumarate in clinical trials for treating Chronic Obstructive Pulmonary Disease (COPD). Formoterol Fumarate is a long-acting bronchodilator medication that helps open airways in the lungs. Multiple studies have investigated its safety, efficacy, and various delivery methods to improve breathing and quality of life for COPD patients.

Table of Contents

What is Formoterol Fumarate?

Formoterol Fumarate is a medication used to treat respiratory conditions. It belongs to a class of drugs called long-acting beta-2 agonists (LABAs). This medication is also known by several brand names, including Perforomist, Foradil, and Atimos[1][2].

Conditions Treated

Formoterol Fumarate is primarily used to treat:

  • Asthma: A chronic lung condition characterized by inflammation and narrowing of the airways, leading to breathing difficulties[3].
  • Chronic Obstructive Pulmonary Disease (COPD): A group of lung diseases, including chronic bronchitis and emphysema, that cause airflow blockage and breathing-related problems[4].
  • Bronchiolitis Obliterans: A rare and serious lung disease that can occur after stem cell transplantation[5].

How It Works

Formoterol Fumarate works by relaxing the muscles around the airways in your lungs. This action helps to open up the airways, making it easier to breathe. As a long-acting medication, its effects can last for up to 12 hours, providing extended relief from symptoms[4].

Forms and Administration

Formoterol Fumarate is available in several forms:

  • Dry Powder Inhaler (DPI): This is a device that delivers the medication as a fine powder that you inhale. Examples include the Foradil Aerolizer and Pressair devices[6].
  • Metered-Dose Inhaler (pMDI): This device delivers the medication as a spray that you inhale. It’s sometimes referred to as a “puffer”[2].
  • Nebulizer Solution: This is a liquid form of the medication that is turned into a fine mist by a machine called a nebulizer. You then inhale the mist through a mask or mouthpiece. The brand name for this form is Perforomist[1].

The dosage and frequency of use can vary depending on your specific condition and the form of the medication. Always follow your doctor’s instructions carefully.

Effectiveness

Clinical studies have shown that Formoterol Fumarate is effective in improving lung function and reducing symptoms in patients with asthma and COPD. Key measures of effectiveness include:

  • FEV1 (Forced Expiratory Volume in 1 second): This is a measure of how much air you can exhale in one second. Formoterol Fumarate has been shown to improve FEV1 in patients with respiratory conditions[6].
  • Reduction in exacerbations: Formoterol Fumarate can help reduce the frequency of sudden worsening of symptoms (exacerbations) in COPD patients[4].
  • Improved quality of life: Patients using Formoterol Fumarate often report improvements in their overall quality of life and ability to perform daily activities[4].

Safety and Side Effects

While Formoterol Fumarate is generally considered safe and effective when used as prescribed, it can cause side effects in some patients. Common side effects may include:

  • Increased heart rate
  • Tremors or shakiness
  • Headache
  • Nausea
  • Changes in blood pressure

In rare cases, more serious side effects can occur. These may include severe allergic reactions, worsening of asthma symptoms, or cardiovascular effects. It’s important to discuss any side effects with your healthcare provider[7].

Use in Special Populations

Formoterol Fumarate has been studied in various patient groups:

  • Adolescents: Some formulations of Formoterol Fumarate are approved for use in adolescents aged 12 and older with asthma[2].
  • Children: Research has been conducted on the use of Formoterol Fumarate in children with asthma, but it’s important to note that the medication should only be used in children under close medical supervision[8].
  • Elderly patients: Older adults with COPD often use Formoterol Fumarate, but they may require careful monitoring due to potential age-related changes in drug metabolism and increased risk of side effects[4].

Ongoing Research

Research on Formoterol Fumarate is ongoing, with studies exploring its use in various combinations with other medications and in different patient populations. Some areas of current research include:

  • Combination therapies: Studies are investigating the effectiveness of Formoterol Fumarate when combined with other medications, such as corticosteroids like beclomethasone dipropionate[3].
  • Long-term safety: Researchers are conducting long-term studies to further evaluate the safety of Formoterol Fumarate with extended use[4].
  • Use in specific conditions: The potential benefits of Formoterol Fumarate are being explored in conditions like bronchiolitis obliterans following stem cell transplantation[5].

As with any medication, it’s crucial to use Formoterol Fumarate exactly as prescribed by your healthcare provider. Regular check-ups and open communication with your doctor about your symptoms and any side effects are essential for optimal management of your respiratory condition.

Aspect Details
Drug Name Formoterol Fumarate
Primary Use Treatment of Chronic Obstructive Pulmonary Disease (COPD)
Administration Methods Nebulizers, Dry Powder Inhalers (DPIs), Metered-Dose Inhalers (MDIs)
Dosages Studied Ranging from 6 μg to 40 μg, with common doses of 12 μg and 20 μg
Trial Durations 12 to 56 weeks
Primary Outcomes Lung function (FEV1), COPD exacerbation rates, quality of life measures
Secondary Outcomes Safety assessments, use of rescue medication, physical exam results
Combination Therapies Studied with aclidinium bromide and beclomethasone dipropionate
Key Findings Improved lung function, reduced exacerbation rates, generally well-tolerated

FAQ

  • What is Formoterol Fumarate? Formoterol Fumarate is a long-acting bronchodilator medication used to treat Chronic Obstructive Pulmonary Disease (COPD). It works by relaxing and opening the airways in the lungs to make breathing easier.
  • How is Formoterol Fumarate administered in clinical trials? In clinical trials, Formoterol Fumarate has been administered through various methods, including nebulizers, dry powder inhalers (DPIs), and metered-dose inhalers (MDIs). Some studies have compared different delivery methods to assess their effectiveness.
  • What are the main outcomes measured in Formoterol Fumarate clinical trials? The main outcomes measured include lung function (often through FEV1 – forced expiratory volume in 1 second), frequency of COPD exacerbations, quality of life measures, and safety assessments such as adverse events and changes in vital signs.
  • How long do typical clinical trials for Formoterol Fumarate last? The duration of clinical trials for Formoterol Fumarate varies, but many last between 12 to 52 weeks. Some long-term safety studies have extended up to 56 weeks to assess the medication's effects over prolonged use.
  • Are there any combination therapies being studied with Formoterol Fumarate? Yes, some clinical trials have investigated combination therapies. For example, studies have looked at the combination of Formoterol Fumarate with other medications like aclidinium bromide or beclomethasone dipropionate to potentially enhance treatment efficacy for COPD patients.

Ongoing Clinical Trials on Formoterol Fumarate

  • Evaluation of inhaled formoterol fumarate to prevent lung complications after chest cancer surgery in high-risk patients

    Recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    France

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma Not Well Controlled

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Hungary Italy Poland Romania Spain

  • Study on the Effectiveness and Safety of Budesonide, Glycopyrronium, and Formoterol Inhaler for Adults and Adolescents with Severe Asthma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Czechia Germany Greece Portugal Slovakia

  • Study on the Effectiveness and Safety of Budesonide and Formoterol Fumarate for Patients with Poorly Controlled Asthma

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Italy Spain

  • Study on the Effects of Budesonide, Glycopyrronium, and Formoterol on Exercise in Patients with Chronic Obstructive Pulmonary Disease (COPD)

    Not recruiting

    1 1 1
    Investigated diseases:
    Investigated drugs:
    Germany Spain

  • Study on the Effectiveness of Beclometasone, Glycopyrronium, and Formoterol in COPD Patients with Asthma Characteristics

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Study Comparing Trelegy with LABA-LAMA Drug Combination for Improving COPD Control in High-Risk Patients

    Not recruiting

    1 1 1 1
    Investigated diseases:
    Investigated drugs:
    Spain

Glossary

  • COPD: Chronic Obstructive Pulmonary Disease, a group of lung diseases that block airflow and make it difficult to breathe.
  • FEV1: Forced Expiratory Volume in 1 second, a measure of how much air a person can exhale in one second. It's commonly used to assess lung function.
  • Bronchodilator: A medication that relaxes the muscles around the airways, making it easier to breathe.
  • Nebulizer: A device that turns liquid medicine into a fine mist that can be inhaled into the lungs.
  • Dry Powder Inhaler (DPI): A device that delivers medication in the form of a dry powder that is inhaled into the lungs.
  • Metered-Dose Inhaler (MDI): A pressurized inhaler that delivers a specific amount of medication in aerosol form.
  • Exacerbation: A worsening of COPD symptoms that may require additional treatment or hospitalization.
  • Placebo: An inactive substance used in clinical trials to compare the effects of a medication against no treatment.
  • Double-blind study: A type of clinical trial where neither the participants nor the researchers know who is receiving the actual medication or placebo.
  • Spirometry: A common test used to assess how well your lungs work by measuring how much air you inhale and exhale.

References

  1. https://clinicaltrials.gov/study/NCT00633776
  2. https://clinicaltrials.gov/study/NCT01803087
  3. https://clinicaltrials.gov/study/NCT01191424
  4. https://clinicaltrials.gov/study/NCT01488019
  5. https://clinicaltrials.gov/study/NCT01560689
  6. https://clinicaltrials.gov/study/NCT02796651
  7. https://clinicaltrials.gov/study/NCT01437540
  8. https://clinicaltrials.gov/study/NCT01658891